HUMAN LYMPHOCYTES CLONALLY TRANSFORMED BY EBV
HUMAN LYMPHOCYTES CLONALLY TRANSFORMED BY EBV
批准号:
3173120
负责人:
Nathaniel A. Brown
金额:
$10.23万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-07-01 至 1986-12-31
关键词:
B lymphocyte Burkitt's lymphoma Epstein Barr virus embryo /fetus cell /tissue gene expression genetic manipulation histocompatibility antigens human tissue immunoglobulin genes leukocyte activation /transformation neoplasm /cancer immunology oncogenic virus tissue /cell culture viral carcinogenesis virus antigen
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The precise ontogenetic range of human lymphocytes susceptible to
transformation by Epstein-Barr Virus (EBV) has not been defined. Recent
but incomplete evidence suggests that EBV may transform a range of
B-lymphocyte phenotypes, from "early" (non-Ig producing) B-cells through
pre-B cells and B-cells. Analyses of Ig expression and cytogenetic
phenomena in Burkitt tumor cells suggest that the oncogenic event which
distinguishes them from other EBV-transformed cells may be associated with
a particular stage in their Ig-gene differentiation program. This
oncogenic event may include a human c-myc gene translocation. We will
attempt to better define the ontogenetic range of human lymphocytes
susceptible to EBV-mediated transformation. Primary mononuclear cells from
human fetal, neonatal, and adult tissues will be clonally transformed in
agarose medium. Clonally propagated lines will then be phenotyped by
analysis of Ig expression, surface "Ia" antigen, and other surface
epitopes. Karyotype analyses will also be done. The cell clones will then
be analyzed for their patterns of Ig gene rearrangements. Cell clones with
aberrant rearrangements of non-expressed Ig gene alleles will be examined
for evidence of rearrangement of the cellular c-myc gene, or chromosomal
translocation. The results of our studies should yield a clearer picture
of the stages of human (B-) lymphocyte ontogeny which are susceptible to
transformation by EBV. We may be able to partially illuminate how
clinically malignant B-cell clones emerge from a polyclonally transformed
population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NOVEL L-NUCLEOSIDE COMBINATION ANTI-HBV THERAPY
-
批准号:6344473
-
项目类别:
-
资助金额:$58.95万
-
财政年份:2001
-
负责人:Nathaniel A. Brown
-
依托单位:
NOVEL L-NUCLEOSIDE COMBINATION ANTI-HBV THERAPY
-
批准号:6536053
-
项目类别:
-
资助金额:$40.42万
-
财政年份:2001
-
负责人:Nathaniel A. Brown
-
依托单位:
CLONAL VIRULENCE FEATURES OF THE EBV TERMINAL REGION
-
批准号:3173122
-
项目类别:
-
资助金额:$2.64万
-
财政年份:1987
-
负责人:Nathaniel A. Brown
-
依托单位:
CLONAL VIRULENCE FEATURES OF THE EBV TERMINAL REGION
-
批准号:3173123
-
项目类别:
-
资助金额:$9.66万
-
财政年份:1987
-
负责人:Nathaniel A. Brown
-
依托单位:
CLONAL VIRULENCE FEATURES OF THE EBV TERMINAL REGION
-
批准号:3173121
-
项目类别:
-
资助金额:$15.9万
-
财政年份:1987
-
负责人:Nathaniel A. Brown
-
依托单位:
CLONAL VIRULENCE FEATURES OF THE EBV TERMINAL REGION
-
批准号:3173116
-
项目类别:
-
资助金额:$4.8万
-
财政年份:1983
-
负责人:Nathaniel A. Brown
-
依托单位:
HUMAN LYMPHOCYTES CLONALLY TRANSFORMED BY EBV
-
批准号:3173119
-
项目类别:
-
资助金额:$9.53万
-
财政年份:1983
-
负责人:Nathaniel A. Brown
-
依托单位:
ANOMALOUS GENE REARRANGEMENTS IN EBV-TRANSFORMED CELLS
-
批准号:3173117
-
项目类别:
-
资助金额:$2.68万
-
财政年份:1983
-
负责人:Nathaniel A. Brown
-
依托单位:
HUMAN LYMPHOCYTES CLONALLY TRANSFORMED BY EBV
-
批准号:3173118
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1983
-
负责人:Nathaniel A. Brown
-
依托单位:
海外基金